Richter, J., Beksac, M., Corso, A., Schofield, O., Olivier, D., Cooper, L., Harrison, O., Bitetti, J., Kazeem, B., Bates, A., Boytsov, N., McNamara, S., Merchant, A., Lloyd, C., Crossman-Morgan, C., Meader, N., Purser, M., Ballew, N. (2025). Indirect treatment comparison of belantamab mafodotin + pomalidomide + dexamethasone versus comparator regimens in lenalidomide-exposed relapsed/refractory multiple myeloma: A network meta-analysis. Blood. https://doi.org/10.1182/blood-2025-7567